Search
for
Sort by
Research 301–330 of 1000+
- Farmácia São Lázaro - Porto e nos Serviços Farmacêuticos do Hospital Privado de Vila Real (Grupo Trofa Saúde) - Vila Real
- Farmácia Militar do Laboratório Nacional do Medicamento, Porto e Serviços Farmacêuticos do Centro Hospitalar Universitário do Porto (Hospital de Santo António), EPE, Porto
- 5-α-Reductase type 2 deficiency: is there a genotype-phenotype correlation? A review
- Efficacy and safety of topical 3% minoxidil for facial hair enhancement in transmen: a randomized, double-blind, placebo-controlled trial
- A pilot study to evaluate effectiveness of botulinum toxin in treatment of androgenetic alopecia in males
- Anabolic-Androgenic Steroids and Cardiometabolic Derangements
- P-18 THREE BODY PROBLEM PATIENT: EHLER DANLOS SYNDROME COMBINED WITH HYPOPHOSPHATASIA AND FATTY ACID OXIDATION DEFECT
- Glucocorticoids and Risk of Venous Thromboembolism in Asthma Patients Aged 20–59 Years in the United Kingdom’s CPRD 1995–2015
- Cardiovascular effects of hormone therapy for prostate cancer
- The Role of the Athletic Trainer in Providing Care to Transgender and Gender-Diverse Patients: Considerations for Medical Affirmation—Part II
- Assessment of efficacy of different botulinum toxin A concentrations in the treatment of androgenetic alopecia assessed by dermoscopy
- Alopecia secondary to poly-L-lactic acid dermal fillers
- The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial
- Efficacy of topical minoxidil in enhancing beard growth in a group of transgender assigned female at birth individuals on gender affirming hormone therapy
- Dermatologic care of the lesbian, gay, bisexual and transgender community of India
- Studies on the persistence of estradiol benzoate and nortestosterone decanoate in hair of cattle following treatment with growth promoters, determined by ultra-high-performance liquid chromatography–tandem mass spectrometry
- Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
- In Vitro and In Vivo Assessment of Metabolic Drug Interaction Potential of Dutasteride with Ketoconazole
- Impacts of Anabolic-androgenic steroid supplementation on female health and offspring: Mechanisms, side effects, and medical perspectives
- Hirsutism in a Female Adolescent Induced by Long-Acting Injectable Risperidone
- Beyond Minoxidil: Off-Label Therapies for Male Androgenetic Alopecia—A Systematic Review with Network Meta-Analyses
- Body composition and physical fitness in transgender versus cisgender individuals: a systematic review with meta-analysis
- Gender-Affirming Hormonal Treatment in Transgender People Assigned Female at Birth (AFAB)
- The Use of Botulinum Toxin in the Treatment of Androgenetic Alopecia: A Systematic Review
- Part II. Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show?
- Clinical and preclinical approach in AGA treatment: a review of current and new therapies in the regenerative field
- The Need and Management of hormone Imbalances in Women
- Dunnigan-Type Familial Partial Lipodystrophy: Understanding and Treating the Syndrome
- Finasteride promotes worsening of the cardiac deleterious effects of nandrolone decanoate and protects against genotoxic and cytotoxic damage
- Androgenetic Alopecia: Clinical Aspects and Treatment